Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_204cbc5d4df75e09c08338be3bd8fa81 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55583 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-00 |
filingDate |
2011-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fc80bdefc0ec489f8bee93a4c30b9e81 |
publicationDate |
2011-11-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
AU-2011226992-A1 |
titleOfInvention |
Immunostimulatory and vaccine compositions |
abstract |
The present invention provides an immunostimulatory composition comprising mannans, wherein at least 75% of the mannans are greater than about 1000 kDa and/or have at least 150 aldehyde groups. The present invention also provides for the use of this composition in vaccination and gene therapy methods, together with processes for its preparation. |
priorityDate |
2010-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |